Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/23/2010WO2010106191A1 Pharmaceutical composition presenting anti-inflammatory properties
09/23/2010WO2010106187A2 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders
09/23/2010WO2010106166A2 Aryloxyanilide derivatives
09/23/2010WO2010106145A1 Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments
09/23/2010WO2010106106A1 2, 5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
09/23/2010WO2010106097A1 Substituted pyrimidines for the treatment of cancer
09/23/2010WO2010106083A1 Combination therapies for treating metabolic disorders
09/23/2010WO2010106082A1 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
09/23/2010WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists
09/23/2010WO2010106076A1 Ppar metabolic stimulator based on unsaturated free fatty acid esters, oily composition and food additive containing same
09/23/2010WO2010106046A1 Macrocyclic lactone drug delivery system
09/23/2010WO2010106028A1 Use of a kinase inhibitor for the treatment of thymoma
09/23/2010WO2010106016A1 Pyrimidine derivatives used as itk inhibitors
09/23/2010WO2010106006A1 Microbiocidally active medicament
09/23/2010WO2010105969A1 Process for the preparation of pyrazole derivatives
09/23/2010WO2010105960A1 Substituted pyridine derivatives and their medical use
09/23/2010WO2010105930A1 Carbamate derivatives in particular for the treatment of neurological disorders
09/23/2010WO2010105910A1 Fosfluconazole derivatives, synthesis, and use in long acting formulations
09/23/2010WO2010105824A1 Retigabine tablets, preferably having modified release
09/23/2010WO2010105823A1 Solid retigabine in non-crystalline form
09/23/2010WO2010105770A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010WO2010105750A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/23/2010WO2010105691A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
09/23/2010WO2010105673A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
09/23/2010WO2010105672A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
09/23/2010WO2010105454A1 Adenosine triphosphate intercalated hydrotalcite film and preparation method therefor
09/23/2010WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression
09/23/2010WO2010105342A1 Transdermal pharmaceutical preparation and administration of tirofiban
09/23/2010WO2010105298A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof
09/23/2010WO2010087565A3 Novel use of piperine
09/23/2010WO2010086736A3 Use of the combination of resveratrol with cysteine and derivatives thereof
09/23/2010WO2010084325A3 Process for isolating tigecycline
09/23/2010WO2010083537A3 Optimal biological marker for the biological potency of emblica officinalis gaertn. (amla) fruit-methods and products thereof
09/23/2010WO2010081722A3 Orally disintegrating tablets for the treatment of pain
09/23/2010WO2010081662A3 Methods for identifying patients who will respond well to cancer treatment
09/23/2010WO2010081622A3 Food supplement for the treatment of neuropathies
09/23/2010WO2010079514A4 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
09/23/2010WO2010077740A3 Novel antiviral compounds, compositions, and methods of use
09/23/2010WO2010077734A3 Novel antiviral compounds, compositions, and methods of use
09/23/2010WO2010075315A3 Topical formulations of flap inhibitors for administration to an eye
09/23/2010WO2010075314A3 Topical formulations of flap inhibitors for the treatment of dermatological conditions
09/23/2010WO2010074460A3 Novel pharmaceutical composition for ameliorating side effects of a lipase inhibitor
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010WO2010072774A3 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal
09/23/2010WO2010067980A3 Histone deacetylase inhibitor that reactivates hiv-1 proviruses from latently hiv-infected cells
09/23/2010WO2010065563A3 Apratoxin therapeutic agents: mechanism and methods of treatment
09/23/2010WO2010065069A3 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
09/23/2010WO2010062824A3 Enhanced bioactive formulations of resveratrol
09/23/2010WO2010062205A4 Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol
09/23/2010WO2010060070A3 Indolinone modulators of dopamine receptor
09/23/2010WO2010059639A3 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
09/23/2010WO2010059633A3 Compounds for treating parasitic disease
09/23/2010WO2010059575A3 Combination therapy for the treatment of cancer
09/23/2010WO2010059401A3 Compounds that expand hematopoietic stem cells
09/23/2010WO2010059245A3 Compositions and methods for treating or preventing radiation injury
09/23/2010WO2010058926A3 Pharmaceutical composition containing ginger extract or shogaol
09/23/2010WO2010058297A9 The use of ph-sensitive, acid-stable metal-binding nanoparticles
09/23/2010WO2010056767A8 Thiochromene derivatives as hif hydroxylase inhibitors
09/23/2010WO2010042933A3 Inhibition and treatment of prostate cancer metastasis
09/23/2010WO2010038091A3 Compositions comrrising amlodipine and bisoprolol
09/23/2010WO2010033425A3 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
09/23/2010WO2010033424A3 Nutritional support of the immune system during anti-cancer treatment
09/23/2010WO2010025872A3 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl
09/23/2010WO2010022383A3 Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
09/23/2010WO2010009155A3 Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
09/23/2010WO2009142827A4 Compounds and methods for the treatment of viral infection
09/23/2010WO2009134718A8 Progesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
09/23/2010WO2009132774A8 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010WO2009110983A8 Retinaldehyde in the treatment of obesity, diabetes and other conditions
09/23/2010WO2009106467A3 Stabilized, antimicrobially effective composition with a content of bispyridinium alkane
09/23/2010WO2009100716A3 Implantable products comprising nanoparticles
09/23/2010WO2009065897A3 Inhibitors of malt1 proteolytic activity and uses thereof
09/23/2010WO2006074207A3 Inhibitors of checkpoint kinases
09/23/2010US20100242127 Methods to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression
09/23/2010US20100241219 Medicament delivery article, accessory & system
09/23/2010US20100241197 Methods of using nitroxides in conjunction with photosensitizers and sonosensitizers
09/23/2010US20100241059 Method and portable device for treating skin disorders
09/23/2010US20100240899 when the plasma nicotinic acid or nicotinuric acid curves are deconvoluted using the Wagner-Nelson method; side effect reduction
09/23/2010US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/23/2010US20100240887 New methods of producing HHT
09/23/2010US20100240876 Replikins and methods of identifying replikin-containing sequences
09/23/2010US20100240769 Olive waste recovery
09/23/2010US20100240768 Novel nutraceuticalcompositions containing thymol and/or p-cymene or plant extracts for cognition
09/23/2010US20100240767 Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
09/23/2010US20100240766 Agent for Improving Carcass Performance in Finishing Hogs
09/23/2010US20100240765 Surfactant peroxycarboxylic acid compositions
09/23/2010US20100240764 Use of S-Clenbuterol
09/23/2010US20100240763 Method to Determine and Biomarker for Treatment Efficacy With Ssri, Snri, and Sari Antidepressants
09/23/2010US20100240761 Bronchodilating beta-agonist compositions and methods
09/23/2010US20100240760 Biomarkers for Efficacy of Aliskiren as a Hypertensive Agent
09/23/2010US20100240758 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic
09/23/2010US20100240757 Systems and methods for delivering a fluid drug
09/23/2010US20100240756 Compounds for treating inflammation and pain
09/23/2010US20100240755 Therapeutic and cosmetic compositions for treatment of skin
09/23/2010US20100240754 Unsaturated fatty amino acid derivatives and use thereof in dermal cosmetology
09/23/2010US20100240753 Effective pharmaceutical carrier for poorly bioavailable drugs
09/23/2010US20100240751 Methods
09/23/2010US20100240749 Anesthetic spray composition
09/23/2010US20100240748 Tetrahydronaphthalen-2-ol derivatives
1 ... 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 ... 7860